文献速递眼底病与葡萄膜炎

中心性浆液性脉络膜视网膜病变患者发生渗出性年龄相关性黄斑变性的风险:一项全国性队列研究

RISK OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: A Nationwide Cohort Study.
PubMed 文献 · Retina · 2022-01-01

该基于人群的队列研究纳入2015年1月至2019年12月年龄30至80岁的中心性浆液性脉络膜视网膜病变(CSC)患者,评估其发生渗出性年龄相关性黄斑变性(AMD)的风险。CSC组渗出性AMD发生率为1.44%,非CSC组为0.32%,CSC组风险显著更高(调整后风险比4.86,95%CI 2.98至5.88,P<0.001)。结论提示CSC患者渗出性AMD风险增加,尤其在亚洲人群中可能存在关联。

要点

  • CSC患者渗出性AMD发生率为1.44%,非CSC组为0.32%。
  • CSC组渗出性AMD风险显著更高,调整后风险比4.86(95%CI 2.98至5.88,P<0.001)。
  • 研究期间CSC年发病率最新一年为每10万人19.61(95%CI 19.58至19.63)。

核心结论

  • CSC患者发生渗出性AMD的风险增加,证据支持CSC与渗出性AMD之间可能存在关联,尤其在亚洲人群中。

研究设计与样本

  • 基于人群的队列研究,最终于2015年1月至2019年12月进行,纳入全人群年龄30至80岁的所有CSC患者。
  • 研究组纳入11,492例CSC患者,非CSC组纳入22,984例。
  • 采用Log-rank分析和Cox比例风险回归分析评估CSC组相比非CSC组的渗出性AMD风险。

主要发现

  • 近5年研究期间共识别36,053例新发CSC患者,最新一年年发病率为每10万人19.61(95%CI 19.58至19.63)。
  • CSC组渗出性AMD 166例(1.44%),非CSC组73例(0.32%)。
  • CSC组渗出性AMD风险显著高于非CSC组(调整后风险比4.86,95%CI 2.98至5.88,P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate the risk of incident age-related macular degeneration (AMD) in patients with central serous chorioretinopathy (CSC). METHODS: This population-based cohort study was finally conducted from January 2015 to December 2019. All patients with CSC from the entire population aged between 30 and 80 years were included. The incidence of CSC was estimated. Log-rank analysis and Cox proportional hazards regression analysis was used to evaluate the risk of exudative AMD in the CSC group compared with the non-CSC group. RESULTS: During a recent 5-year study period, 36,053 patients were identified as having incident CSC. The annual incidence in the latest year was 19.61 (95% confidence interval, 19.58 to 19.63) per 100,000 people. A total of 11,492 patients were included in the study group and 22,984 in the non-CSC group. The CSC and non-CSC groups included 166 (1.44%) and 73 (0.32%) cases of exudative AMD, respectively. The risk of exudative AMD was significantly higher in the CSC group than in the non-CSC group (adjusted hazard ratio: 4.86; 95% confidence interval: 2.98 to 5.88; P < 0.001). CONCLUSION: This study showed that subjects with CSC are at an increased risk of exudative AMD. This evidence supports a possible link between CSC and exudative AMD, particularly in Asian populations.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Lee JY, Bae K. RISK OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: A Nationwide Cohort Study. Retina. 2022. PMID: 35067609. doi:10.1097/IAE.0000000000003412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。